Fate of chronic myeloid leukemia patients treated with allogeneic bone marrow transplantation or chemotherapy and/or interferon at a single center: long-term results
- 1 January 2002
- journal article
- research article
- Published by Springer Nature in Bone Marrow Transplantation
- Vol. 29 (1) , 1-8
- https://doi.org/10.1038/sj.bmt.1703323
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Efficacy and Safety of a Specific Inhibitor of the BCR-ABL Tyrosine Kinase in Chronic Myeloid LeukemiaNew England Journal of Medicine, 2001
- Monitoring Treatment and Survival in Chronic Myeloid LeukemiaJournal of Clinical Oncology, 1999
- Thiotepa, busulfan and cyclophosphamide as a preparative regimen for allogeneic transplantation for advanced chronic myelogenous leukemiaBone Marrow Transplantation, 1999
- Relapse of chronic myeloid leukaemia 14 years after allogeneic bone marrow transplantationBone Marrow Transplantation, 1999
- Relapsed chronic myeloid leukemia in accelerated phase 10 years after allogeneic bone marrow transplantation: full chimera reconversion with donor peripheral blood stem cells infusionBone Marrow Transplantation, 1998
- Interferon Alfa Versus Chemotherapy for Chronic Myeloid Leukemia: A Meta-analysis of Seven Randomized TrialsJNCI Journal of the National Cancer Institute, 1997
- Long-term results after allogeneic bone marrow transplantation for chronic myelogenous leukemia in chronic phase: a report from the Chronic Leukemia Working Party of the European Group for Blood and Marrow TransplantationBone Marrow Transplantation, 1997
- Prolonged Survival in Chronic Myelogenous Leukemia after Cytogenetic Response to Interferon-α TherapyAnnals of Internal Medicine, 1995
- Bone Marrow Transplantation for Patients with Chronic Myeloid LeukemiaNew England Journal of Medicine, 1986
- Bone-Marrow TransplantationNew England Journal of Medicine, 1975